Alcohol withdrawal syndrome in critically ill patients: Protocolized versus nonprotocolized management

Jeremiah J. Duby, Andrew J. Berry, Paricheh Ghayyem, Machelle D. Wilson, Christine S Cocanour

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Approximately 18% to 25% of patients with alcohol use disorders admitted to the hospital develop alcohol withdrawal syndrome (AWS). Symptom-triggered dosing of benzodiazepines (BZDs) seems to lead to shorter courses of treatment, lower cumulative BZD dose, and more rapid control of symptoms in nonYcritically ill patients. This study compares the outcomes of critically ill patients with AWS when treated using a protocolized, symptom-triggered, dose escalation approach versus a nonprotocolized approach.

Methods: This is a retrospective pre-post study of patients 18 years or older with AWS admitted to an intensive care unit (ICU). The preintervention cohort (PRE) was admitted between February 2008 and February 2010. The postintervention cohort (POST) was admitted between February 2012 and January 2013. The PRE patients were treated by physician preference and compared with POST patients who were given escalating doses of BZDs and/or phenobarbital according to an AWS protocol, titrating to light sedations (Richmond Agitation Sedation Scale score of 0 to -2).

Results: There were 135 episodes of AWS in 132 critically ill patients. POST patients (n = 75) were younger (50.7 [13.8] years vs. 55.7 [8.7] years, p = 0.03) than PRE patients (n = 60). Sequential Organ Failure Assessment (SOFA) scores were higher in the PRE group (6.1 [3.7] vs. 3.9 [2.9], p = 0.0004). There was a significant decrease in mean ICU length of stay from 9.6 (10.5) days to 5.2 (6.4) days (p = 0.0004) in the POST group. The POST group also had significantly fewer ventilator days (5.6 < 13.9] days vs. 1.31 < 5.6] days, p < 0.0001) as well as a significant decrease in BZD use (319 [1,084] mg vs. 93 [171] mg, p = 0.002). There were significant differences between the two cohorts with respect to the need for continuous sedation (p < 0.001), duration of sedation ( p < 0.001), and intubation secondary to AWS ( p < 0.001). In all of these outcomes, the POST cohort had a notably lower frequency of occurrence.

Conclusion: A protocolized treatment approach of AWS in critically ill patients involving symptom-triggered, dose escalations of diazepam and phenobarbital may lead to a decreased ICU length of stay, decreased time spent on mechanical ventilation, and decreased BZD requirements.

Original languageEnglish (US)
Pages (from-to)938-943
Number of pages6
JournalJournal of Trauma and Acute Care Surgery
Volume77
Issue number6
DOIs
StatePublished - Dec 11 2014

Fingerprint

Critical Illness
Alcohols
Benzodiazepines
Intensive Care Units
Phenobarbital
Length of Stay
Organ Dysfunction Scores
Mechanical Ventilators
Diazepam
Artificial Respiration
Intubation
Outcome Assessment (Health Care)
Physicians
Light
Therapeutics

Keywords

  • Alcohol withdrawal syndrome
  • Benzodiazepines
  • ICU
  • Sedation

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Surgery
  • Medicine(all)

Cite this

Alcohol withdrawal syndrome in critically ill patients : Protocolized versus nonprotocolized management. / Duby, Jeremiah J.; Berry, Andrew J.; Ghayyem, Paricheh; Wilson, Machelle D.; Cocanour, Christine S.

In: Journal of Trauma and Acute Care Surgery, Vol. 77, No. 6, 11.12.2014, p. 938-943.

Research output: Contribution to journalArticle

Duby, Jeremiah J. ; Berry, Andrew J. ; Ghayyem, Paricheh ; Wilson, Machelle D. ; Cocanour, Christine S. / Alcohol withdrawal syndrome in critically ill patients : Protocolized versus nonprotocolized management. In: Journal of Trauma and Acute Care Surgery. 2014 ; Vol. 77, No. 6. pp. 938-943.
@article{5243c7341638424794f2ac388f5a8618,
title = "Alcohol withdrawal syndrome in critically ill patients: Protocolized versus nonprotocolized management",
abstract = "Background: Approximately 18{\%} to 25{\%} of patients with alcohol use disorders admitted to the hospital develop alcohol withdrawal syndrome (AWS). Symptom-triggered dosing of benzodiazepines (BZDs) seems to lead to shorter courses of treatment, lower cumulative BZD dose, and more rapid control of symptoms in nonYcritically ill patients. This study compares the outcomes of critically ill patients with AWS when treated using a protocolized, symptom-triggered, dose escalation approach versus a nonprotocolized approach.Methods: This is a retrospective pre-post study of patients 18 years or older with AWS admitted to an intensive care unit (ICU). The preintervention cohort (PRE) was admitted between February 2008 and February 2010. The postintervention cohort (POST) was admitted between February 2012 and January 2013. The PRE patients were treated by physician preference and compared with POST patients who were given escalating doses of BZDs and/or phenobarbital according to an AWS protocol, titrating to light sedations (Richmond Agitation Sedation Scale score of 0 to -2).Results: There were 135 episodes of AWS in 132 critically ill patients. POST patients (n = 75) were younger (50.7 [13.8] years vs. 55.7 [8.7] years, p = 0.03) than PRE patients (n = 60). Sequential Organ Failure Assessment (SOFA) scores were higher in the PRE group (6.1 [3.7] vs. 3.9 [2.9], p = 0.0004). There was a significant decrease in mean ICU length of stay from 9.6 (10.5) days to 5.2 (6.4) days (p = 0.0004) in the POST group. The POST group also had significantly fewer ventilator days (5.6 < 13.9] days vs. 1.31 < 5.6] days, p < 0.0001) as well as a significant decrease in BZD use (319 [1,084] mg vs. 93 [171] mg, p = 0.002). There were significant differences between the two cohorts with respect to the need for continuous sedation (p < 0.001), duration of sedation ( p < 0.001), and intubation secondary to AWS ( p < 0.001). In all of these outcomes, the POST cohort had a notably lower frequency of occurrence.Conclusion: A protocolized treatment approach of AWS in critically ill patients involving symptom-triggered, dose escalations of diazepam and phenobarbital may lead to a decreased ICU length of stay, decreased time spent on mechanical ventilation, and decreased BZD requirements.",
keywords = "Alcohol withdrawal syndrome, Benzodiazepines, ICU, Sedation",
author = "Duby, {Jeremiah J.} and Berry, {Andrew J.} and Paricheh Ghayyem and Wilson, {Machelle D.} and Cocanour, {Christine S}",
year = "2014",
month = "12",
day = "11",
doi = "10.1097/TA.0000000000000352",
language = "English (US)",
volume = "77",
pages = "938--943",
journal = "Journal of Trauma and Acute Care Surgery",
issn = "2163-0755",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Alcohol withdrawal syndrome in critically ill patients

T2 - Protocolized versus nonprotocolized management

AU - Duby, Jeremiah J.

AU - Berry, Andrew J.

AU - Ghayyem, Paricheh

AU - Wilson, Machelle D.

AU - Cocanour, Christine S

PY - 2014/12/11

Y1 - 2014/12/11

N2 - Background: Approximately 18% to 25% of patients with alcohol use disorders admitted to the hospital develop alcohol withdrawal syndrome (AWS). Symptom-triggered dosing of benzodiazepines (BZDs) seems to lead to shorter courses of treatment, lower cumulative BZD dose, and more rapid control of symptoms in nonYcritically ill patients. This study compares the outcomes of critically ill patients with AWS when treated using a protocolized, symptom-triggered, dose escalation approach versus a nonprotocolized approach.Methods: This is a retrospective pre-post study of patients 18 years or older with AWS admitted to an intensive care unit (ICU). The preintervention cohort (PRE) was admitted between February 2008 and February 2010. The postintervention cohort (POST) was admitted between February 2012 and January 2013. The PRE patients were treated by physician preference and compared with POST patients who were given escalating doses of BZDs and/or phenobarbital according to an AWS protocol, titrating to light sedations (Richmond Agitation Sedation Scale score of 0 to -2).Results: There were 135 episodes of AWS in 132 critically ill patients. POST patients (n = 75) were younger (50.7 [13.8] years vs. 55.7 [8.7] years, p = 0.03) than PRE patients (n = 60). Sequential Organ Failure Assessment (SOFA) scores were higher in the PRE group (6.1 [3.7] vs. 3.9 [2.9], p = 0.0004). There was a significant decrease in mean ICU length of stay from 9.6 (10.5) days to 5.2 (6.4) days (p = 0.0004) in the POST group. The POST group also had significantly fewer ventilator days (5.6 < 13.9] days vs. 1.31 < 5.6] days, p < 0.0001) as well as a significant decrease in BZD use (319 [1,084] mg vs. 93 [171] mg, p = 0.002). There were significant differences between the two cohorts with respect to the need for continuous sedation (p < 0.001), duration of sedation ( p < 0.001), and intubation secondary to AWS ( p < 0.001). In all of these outcomes, the POST cohort had a notably lower frequency of occurrence.Conclusion: A protocolized treatment approach of AWS in critically ill patients involving symptom-triggered, dose escalations of diazepam and phenobarbital may lead to a decreased ICU length of stay, decreased time spent on mechanical ventilation, and decreased BZD requirements.

AB - Background: Approximately 18% to 25% of patients with alcohol use disorders admitted to the hospital develop alcohol withdrawal syndrome (AWS). Symptom-triggered dosing of benzodiazepines (BZDs) seems to lead to shorter courses of treatment, lower cumulative BZD dose, and more rapid control of symptoms in nonYcritically ill patients. This study compares the outcomes of critically ill patients with AWS when treated using a protocolized, symptom-triggered, dose escalation approach versus a nonprotocolized approach.Methods: This is a retrospective pre-post study of patients 18 years or older with AWS admitted to an intensive care unit (ICU). The preintervention cohort (PRE) was admitted between February 2008 and February 2010. The postintervention cohort (POST) was admitted between February 2012 and January 2013. The PRE patients were treated by physician preference and compared with POST patients who were given escalating doses of BZDs and/or phenobarbital according to an AWS protocol, titrating to light sedations (Richmond Agitation Sedation Scale score of 0 to -2).Results: There were 135 episodes of AWS in 132 critically ill patients. POST patients (n = 75) were younger (50.7 [13.8] years vs. 55.7 [8.7] years, p = 0.03) than PRE patients (n = 60). Sequential Organ Failure Assessment (SOFA) scores were higher in the PRE group (6.1 [3.7] vs. 3.9 [2.9], p = 0.0004). There was a significant decrease in mean ICU length of stay from 9.6 (10.5) days to 5.2 (6.4) days (p = 0.0004) in the POST group. The POST group also had significantly fewer ventilator days (5.6 < 13.9] days vs. 1.31 < 5.6] days, p < 0.0001) as well as a significant decrease in BZD use (319 [1,084] mg vs. 93 [171] mg, p = 0.002). There were significant differences between the two cohorts with respect to the need for continuous sedation (p < 0.001), duration of sedation ( p < 0.001), and intubation secondary to AWS ( p < 0.001). In all of these outcomes, the POST cohort had a notably lower frequency of occurrence.Conclusion: A protocolized treatment approach of AWS in critically ill patients involving symptom-triggered, dose escalations of diazepam and phenobarbital may lead to a decreased ICU length of stay, decreased time spent on mechanical ventilation, and decreased BZD requirements.

KW - Alcohol withdrawal syndrome

KW - Benzodiazepines

KW - ICU

KW - Sedation

UR - http://www.scopus.com/inward/record.url?scp=84918493957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918493957&partnerID=8YFLogxK

U2 - 10.1097/TA.0000000000000352

DO - 10.1097/TA.0000000000000352

M3 - Article

C2 - 25248063

AN - SCOPUS:84918493957

VL - 77

SP - 938

EP - 943

JO - Journal of Trauma and Acute Care Surgery

JF - Journal of Trauma and Acute Care Surgery

SN - 2163-0755

IS - 6

ER -